Clinical Trial

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A randomized, double-blinded, partial-open, placebo/active-controlled, single/multiple dosing, dose escalation phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of IY-828026 in healthy adult volunteers
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-22.
Status change: Not Yet Recruiting → Recruiting 2026-03-23
Trial Details
NCT Number NCT07433556
Lead Sponsor Il-Yang Pharm. Co., Ltd.
Conditions Healhty
Enrollment 86 participants
Start Date 2026-03-23
Primary Completion 2027-03 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-27